This site uses cookies to bring you the best experience. Find out more
Skip to main content

News

Find Out The Latest

Keep in touch with exciting developments from The Oxford Science Park and its occupiers here.

Contact us on comms@oxfordsp.com if you would like to know more about any of these stories.

You can also follow us on LinkedIn  


Exscientia launches Miami Office to recruit US-based Technology talent as part of continued expansion

Exscientia, the world-leading artificial intelligence (AI) driven Pharmatech company, today announces the opening of its US based Miami office, with recruitment starting immediately. Led by Chief Research Engineer, Adrian Schreyer, Exscientia are recruiting both AI Engineers and Cheminformaticians to join the new Miami office. Members of the team will have extensive opportunities to work in the globally important field of... Read more

Oxford University & Vaccitech welcome UK regulatory emergency use authorisation of coronavirus vaccine

Oxford, UK – Vaccitech Ltd announces that the UK Government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the ChAdOx1 nCoV-19 coronavirus vaccine in the UK. The vaccine was co-invented by Vaccitech and The University of Oxford’s Jenner Institute. The Joint Committee on Vaccination and Immunisation (JCVI)... Read more

Enara Bio relocates to The Oxford Science Park’s newest facility to expand R&D capabilities in the search for novel cancer immunotherapies

Oxford and London, UK – 9th December 2020. Enara Bio, a biotechnology company leveraging its proprietary T-cell/T-cell receptor (TCR) discovery and Dark Antigen™ platforms to deliver targeted cancer immunotherapies, announces its expansion and move to the new Bellhouse Building at The Oxford Science Park. Enara’s move from the Oxford BioEscalator to one of the UK’s largest biomedical innovation centres is in preparation for its future growth... Read more

Innovate UK backs ATDBio & University of Oxford research in single-cell sequencing

New approach expected to increase use of technique in research and diagnosis Oxford, UK, September 8 2020 – ATDBio, a leader in complex oligonucleotide synthesis, and a research team at the Botnar Research Centre, University of Oxford, have been awarded funding by Innovate UK, the UK’s Innovation Agency, to improve single-cell RNA sequencing (scRNA-Seq). By developing new materials for scRNA-Seq, the partners expect to increase its use in... Read more

Oxford Nanopore Technologies partners with UK Government to roll out LamPORE, a new generation of COVID-19 test

Mon 3rd August 2020 Ground-breaking British technology will initially provide hundreds of thousands of fast, accurate, low-cost COVID-19 tests under new agreement with the UK Government, with the potential to build to millions of tests per month The “LamPORE COVID-19” assay provides precise detection of SARS-CoV-2, the virus that causes COVID-19, using Oxford Nanopore’s DNA/RNA sequencing technology. LamPORE is fully scalable... Read more

The Daubeny Project

Imaginative design, inspiring spaces.